InvestorsHub on MSN
Aligos Therapeutics edges higher after update on Phase 2 HBV trial
Shares of Aligos Therapeutics Inc (NASDAQ:ALGS) rose 3.1% on Wednesday after the company provided a progress update on its ...
Explore the potential of bacteriophages as a breakthrough therapy against bacterial infections amidst rising antibiotic resistance.
Solid Biosciences is positioning itself for a potentially “transformative” year as it builds on its 2025 success and centres its pipeline around novel platforms, aiming to overcome investment ...
The United Nations convened the First Session of the General Assembly on 10 January 1946 in London, England. Delegates representing 51 nations attended the session, wherein the scope and purpose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results